Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.56−0.01 (-0.39%)
Close on Nov 17, 2026Market cap $285.84MP/E –Yield –
Alector price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Alector's price to sales ratio was 21.2× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 1.2× to 21.2×, with a median of 4.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 21.2× | +18.8 |
| 2025 | Dec 31, 2025 | 2.4× | −0.6 |
| 2024 | Dec 31, 2024 | 3.0× | −4.0 |
| 2023 | Dec 29, 2023 | 7.0× | +1.3 |
| 2022 | Dec 30, 2022 | 5.7× | −2.6 |
| 2021 | Dec 31, 2021 | 8.3× | −42.7 |
| 2020 | Dec 31, 2020 | 51.0× | +2.3 |
| 2019 | Dec 31, 2019 | 48.7× | – |
See a number that looks wrong?